Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The only trial FDA staff were able to find about the effectiveness of using BPC-157 to treat ulcerative colitis was a meeting abstract reporting on the results of a study using 46 people in which the peptide was given as an enema, not as an injection
The compounding landscape for oral GLP-1 formulations continues to evolve, and glycine inclusion in oral formulations may emerge as formulation science advances
The logic isn't "more peptides = better." It's that these two peptides address different bottlenecks in the healing process
Whether combating leaky gut, IBS, or ulcers, BPC-157 shields and restores the delicate mucosal barrier, supporting systemic healing
Studied in Laboratory binding experiments and animal studies
US$ 24.91
US$ 25.85
US$ 28.04
